273 related articles for article (PubMed ID: 26133709)
1. Time-Dependent Inhibition of hOAT1 and hOAT3 by Anthraquinones.
Ma L; Qin Y; Shen Z; Hu H; Zhou H; Yu L; Jiang H; Zeng S
Biol Pharm Bull; 2015; 38(7):992-5. PubMed ID: 26133709
[TBL] [Abstract][Full Text] [Related]
2. Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug-drug interaction in rats.
Ma L; Zhao L; Hu H; Qin Y; Bian Y; Jiang H; Zhou H; Yu L; Zeng S
J Ethnopharmacol; 2014 May; 153(3):864-71. PubMed ID: 24685584
[TBL] [Abstract][Full Text] [Related]
3. Effects of phenylpropanoids on human organic anion transporters hOAT1 and hOAT3.
Kawasaki T; Takeichi Y; Tomita M; Uwai Y; Epifano F; Fiorito S; Taddeo VA; Genovese S; Nabekura T
Biochem Biophys Res Commun; 2017 Aug; 489(4):375-380. PubMed ID: 28559139
[TBL] [Abstract][Full Text] [Related]
4. The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination.
Wang L; Pan X; Sweet DH
Biochem Pharmacol; 2013 Oct; 86(7):991-6. PubMed ID: 23973525
[TBL] [Abstract][Full Text] [Related]
5. Interaction between rhein acyl glucuronide and methotrexate based on human organic anion transporters.
Yuan Y; Yang H; Kong L; Li Y; Li P; Zhang H; Ruan J
Chem Biol Interact; 2017 Nov; 277():79-84. PubMed ID: 28890383
[TBL] [Abstract][Full Text] [Related]
6. Interaction characteristics of flavonoids with human organic anion transporter 1 (hOAT1) and 3 (hOAT3).
Hong SS; Seo K; Lim SC; Han HK
Pharmacol Res; 2007 Dec; 56(6):468-73. PubMed ID: 17920288
[TBL] [Abstract][Full Text] [Related]
7. Interaction and transport characteristics of mycophenolic acid and its glucuronide via human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Motohashi H; Tsuji Y; Ueo H; Katsura T; Inui K
Biochem Pharmacol; 2007 Jun; 74(1):161-8. PubMed ID: 17462604
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective Inhibition of Renal Basolateral Human Organic Anion Transporter 3 by Lansoprazole Enantiomers.
Hamada Y; Ikemura K; Iwamoto T; Okuda M
Pharmacology; 2018; 101(3-4):176-183. PubMed ID: 29353278
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of selective cyclooxygenase-2 inhibitor lumiracoxib on human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Honjo H; Iwamoto K
Drug Metab Pharmacokinet; 2010; 25(5):450-5. PubMed ID: 20877132
[TBL] [Abstract][Full Text] [Related]
10. Transport of the natural sweetener stevioside and its aglycone steviol by human organic anion transporter (hOAT1; SLC22A6) and hOAT3 (SLC22A8).
Srimaroeng C; Chatsudthipong V; Aslamkhan AG; Pritchard JB
J Pharmacol Exp Ther; 2005 May; 313(2):621-8. PubMed ID: 15644426
[TBL] [Abstract][Full Text] [Related]
11. Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin.
Watanabe H; Sakaguchi Y; Sugimoto R; Kaneko K; Iwata H; Kotani S; Nakajima M; Ishima Y; Otagiri M; Maruyama T
Clin Exp Nephrol; 2014 Oct; 18(5):814-20. PubMed ID: 24185403
[TBL] [Abstract][Full Text] [Related]
12. Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Honjo H; Iwamoto K
Pharmacol Res; 2012 Feb; 65(2):254-60. PubMed ID: 22108572
[TBL] [Abstract][Full Text] [Related]
13. Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K.
Yin J; Wagner DJ; Prasad B; Isoherranen N; Thummel KE; Wang J
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F805-F814. PubMed ID: 31322418
[TBL] [Abstract][Full Text] [Related]
14. Characterization of ochratoxin A transport by human organic anion transporters.
Jung KY; Takeda M; Kim DK; Tojo A; Narikawa S; Yoo BS; Hosoyamada M; Cha SH; Sekine T; Endou H
Life Sci; 2001 Sep; 69(18):2123-35. PubMed ID: 11669456
[TBL] [Abstract][Full Text] [Related]
15. Cl- -dependent upregulation of human organic anion transporters: different effects on transport kinetics between hOAT1 and hOAT3.
Ueo H; Motohashi H; Katsura T; Inui K
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F391-7. PubMed ID: 17429031
[TBL] [Abstract][Full Text] [Related]
16. Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate.
Mizuno N; Takahashi T; Iwase Y; Kusuhara H; Niwa T; Sugiyama Y
Drug Metab Dispos; 2007 Aug; 35(8):1429-34. PubMed ID: 17502342
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective inhibitory effect of flurbiprofen, ibuprofen and naproxen on human organic anion transporters hOAT1 and hOAT3.
Honjo H; Uwai Y; Aoki Y; Iwamoto K
Biopharm Drug Dispos; 2011 Dec; 32(9):518-24. PubMed ID: 22072415
[TBL] [Abstract][Full Text] [Related]
18. Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors.
Cihlar T; Ray AS; Laflamme G; Vela JE; Tong L; Fuller MD; Roy A; Rhodes GR
Antivir Ther; 2007; 12(2):267-72. PubMed ID: 17503669
[TBL] [Abstract][Full Text] [Related]
19. Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).
Uwai Y; Ida H; Tsuji Y; Katsura T; Inui K
Pharm Res; 2007 Apr; 24(4):811-5. PubMed ID: 17372702
[TBL] [Abstract][Full Text] [Related]
20. Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1.
Ueo H; Motohashi H; Katsura T; Inui K
Biochem Pharmacol; 2005 Oct; 70(7):1104-13. PubMed ID: 16098483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
